Ovarian Cancer

Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual tumor. HIPEC increases concentrations of chemotherapy directly within the peritoneal cavity compared with the intravenous route and reduces the systemic side effects associated with prolonged adjuvant intraperitoneal exposure. Furthermore, hyperthermia increases tissue penetration and is synergistic with the therapeutic chemotherapy agents used. In ovarian cancer, evidence is building for its use in both primary and recurrent scenarios.”.

To read more about this study, click here.

Search Surgeon by State

HIPEC Ovarian Cancer Patients Share Their Stories

Dena’s Story

Dena’s Story

Dena Svoboda, 56, never expected a bad case of acid reflux would turn out to be cancer. “I thought it was a gallbladder issue, but it wasn’t,” said Dena, of Sagamore Hills, Ohio. “It ended up being a 25-pound tumor.”

read more
Julie’s Story

Julie’s Story

Julie Khoury, was treated with HIPEC during surgery to treat Ovarian Cancer. She is a Patient of Dr. Shanel Bhagwandin of Jupiter Medical Center.

read more
Susan’s Story; Ovarian Cancer

Susan’s Story; Ovarian Cancer

“Well, you’ve got a tumor” were his first words to me. I had just awakened in a hospital bed on the morning after emergency surgery. It was Tuesday, Oct. 31, 2017. Halloween.

read more
Lori’s Story

Lori’s Story

Lori Moon, of Lincoln, was treated with HIPEC during surgery to treat Ovarian Cancer. She is a Patient of Dr. Thomas Minor of Rhode Island Hospital.

read more
Henrietta’s Story

Henrietta’s Story

“While I knew something was wrong, I would never have guessed ovarian cancer,” Henri said. “It just seemed impossible that I could have it when I had no ovaries.” “

read more